Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShort-Term Debt repayments
Ratios

Fortress Biotech (FBIO) Short-Term Debt repayments: 2013-2024

Historic Short-Term Debt repayments for Fortress Biotech (FBIO) over the last 1 years, with Dec 2024 value amounting to $5.0 million.

  • Fortress Biotech's Short-Term Debt repayments fell 65.80% to $5.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $19.6 million, marking a year-over-year increase of 0.57%. This contributed to the annual value of $9.9 million for FY2024, which is 31.52% down from last year.
  • According to the latest figures from Q4 2024, Fortress Biotech's Short-Term Debt repayments is $5.0 million, which was up 10,100.00% from -$50,000 recorded in Q3 2024.
  • Over the past 5 years, Fortress Biotech's Short-Term Debt repayments peaked at $14.6 million during Q4 2023, and registered a low of -$50,000 during Q3 2024.
  • Its 3-year average for Short-Term Debt repayments is $4.9 million, with a median of $5.0 million in 2024.
  • Data for Fortress Biotech's Short-Term Debt repayments shows a maximum YoY crashed of 4,900.00% (in 2024) over the last 5 years.
  • Over the past 3 years, Fortress Biotech's Short-Term Debt repayments (Quarterly) stood at $5.0 million in 2022, then tumbled by 100.02% to $14.6 million in 2023, then tumbled by 65.80% to $5.0 million in 2024.
  • Its Short-Term Debt repayments was $5.0 million in Q4 2024, compared to -$50,000 in Q3 2024 and $14.6 million in Q4 2023.